Trade

with

Rockwell Medical Inc
(NASDAQ: RMTI)
AdChoices
9.36
-0.69
-6.87%
After Hours :
9.36
0.00
0.00%

Open

9.40

Previous Close

10.05

Volume (Avg)

847.42k (393.50k)

Day's Range

9.13-9.79

52Wk Range

8.66-15.85

Market Cap.

382.78M

Dividend Rate ( Yield )

-

Beta

1.26

Shares Outstanding

40.90M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 52.38M

    • Net Income

    • -48.78M

    • Market Cap.

    • 382.78M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -61.29

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.26

    • Forward P/E

    • -25.97

    • Price/Sales

    • 7.00

    • Price/Book Value

    • -98.04

    • Price/Cash flow

    • -12.79

      • EBITDA

      • -45.95M

      • Return on Capital %

      • -81.38

      • Return on Equity %

      • -488.05

      • Return on Assets %

      • -81.38

      • Book Value/Share

      • -0.10

      • Shares Outstanding

      • 40.90M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 14.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 0.03

        • Cashflow Estimate

        • 0.58

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.40

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 0.27

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 13.93

            • 69.92

            • Pre-Tax Margin

            • -61.29

            • 21.84

            • Net Profit Margin

            • -61.29

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 13.70

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -52.00

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -52.00

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 1.42

              • 1.92

              • Quick Ratio

              • 1.20

              • 1.31

              • Interest Coverage

              • -8.45

              • 17.64

              • Leverage Ratio

              • -

              • 2.03

              • Book Value/Share

              • -0.10

              • 14.62

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -12.38

                • 22.99

                • P/E Ratio 5-Year High

                • -20.65

                • 193.96

                • P/E Ratio 5-Year Low

                • -3.86

                • 87.26

                • Price/Sales Ratio

                • 7.58

                • 3.84

                • Price/Book Value

                • -106.38

                • 3.83

                • Price/Cash Flow Ratio

                • -12.79

                • 14.51

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -488.05

                    (-)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -81.38

                    (-98.70)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -108.13

                    (-)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • 16.02

                  • 2.46

                  • Asset Turnover

                  • 1.33

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -47.06M
                  Operating Margin
                  -89.84
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -12.79
                  Ownership

                  Institutional Ownership

                  26.58%

                  Top 10 Institutions

                  17.01%

                  Mutual Fund Ownership

                  11.43%

                  Float

                  94.34%

                  5% / Insider Ownership

                  10.93%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • iShares Russell 2000 (AU)

                  •  

                    606,555

                  • -1.46

                  • 1.63

                  • Vanguard Total Stock Mkt Idx

                  •  

                    592,226

                  • 0.00

                  • 1.45

                  • Vanguard VIF Small Comp Gr

                  •  

                    431,090

                  • 0.00

                  • 1.07

                  • Vanguard Extended Market Index Fund

                  •  

                    319,836

                  • 3.89

                  • 0.78

                  • Vanguard US Discoveries Fund

                  •  

                    246,578

                  • -2.22

                  • 0.61

                  • iShares Russell 2000 Value

                  •  

                    239,883

                  • 0.26

                  • 0.64

                  • Ohio National Bryton Growth

                  •  

                    219,557

                  • -10.71

                  • 0.55

                  • Ivy Micro Cap Growth Fund

                  •  

                    185,900

                  • 0.00

                  • 0.46

                  • CREF Stock

                  •  

                    146,215

                  • 0.00

                  • 0.36

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    112,115

                  • 0.00

                  • 0.27

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • BlackRock Fund Advisors

                  •  

                    1,017,955

                  • -7.51%

                  • 2.54

                  • Vanguard Group, Inc.

                  •  

                    985,122

                  • +1.29%

                  • 2.46

                  • Granahan Investment Management Inc..

                  •  

                    844,266

                  • -0.20%

                  • 2.06

                  • Wall Street Associates Llc

                  •  

                    682,200

                  • -1.62%

                  • 1.70

                  • State Street Corp

                  •  

                    653,045

                  • -2.59%

                  • 1.63

                  • Credit Suisse First Boston (CSFB)

                  •  

                    635,109

                  • +196.52%

                  • 1.58

                  • Perkins Capital Management Inc

                  •  

                    616,555

                  • +1.16%

                  • 1.54

                  • Essex Investment Management Company, LLC

                  •  

                    570,496

                  • -1.54%

                  • 1.42

                  • Northern Trust Investments, N.A.

                  •  

                    434,154

                  • -11.20%

                  • 1.08

                  • Cormorant Asset Management, LLC

                  •  

                    400,000

                  • 0.00%

                  • 1.00

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Distressed

                  Style

                  Small Growth

                  Rockwell Medical Inc was incorporated in the state of Michigan in 1996. The Company is a fully-integrated biopharmaceutical company targeting end-stage renal disease and chronic kidney disease with products and services for the treat...morement of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company manufactures, sells, delivers and distributes hemodialysis concentrates, along with a full line of ancillary products, to customers in the U.S. and abroad. Dialysate concentrates account for over 93% of its revenue and consist of two products known in the industry as acid and bicarbonate and are packaged as liquid or powder. All of its products are manufactured according to Association for the Advancement of Medical Instrumentation and current good manufacturing practices guidelines. Its...more concentrate products are used in conjunction and are diluted with clean water on-site at the clinic in the dialysis machine, creating dialysate, which works to clean the patient's blood. Its CitraPure concentrate is 100% acetate-free, in contrast to the acetate-based products used for many years. Acetate promotes inflammation so its removal is beneficial to the patient. Dry powder acid concentrate for use with its Dry Acid Mixing System, containing acetic acid, sodium chloride, dextrose and electrolyte additives such as magnesium, potassium, and calcium. It supplies dry acid in 25 gallon cases. Its Dry Acid Concentrate Mixing System is designed for its CitraPure and Dri-Sate Dry Acid product and allows a clinic to mix its acid concentrate on-site. The clinic technician, using a specially designed mixer, adds pre-measured packets of the necessary ingredients to purified water. RenalPure bicarbonate sold in powder form is used mainly in chronic settings. Each clinic mixes bicarbonate on-site as required. SteriLyte bicarbonate is sold in liquid form and is used in acute care settings. It offers ancillary products including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts and other supplies used by hemodialysis providers. Its largest competitor is U.S. based Fresenius Medical Care NA, which is mainly in the business of operating dialysis clinics, as well as manufacturing and marketing dialysis devices, drugs and supplies. The testing, manufacture and sale of its hemodialysis concentrates and the ancillary products it distribute are subject to regulation by numerous governmental authorities, mainly the FDA and corresponding state and foreign agencies.lessless

                  Key People

                  Robert L. Chioini

                  CEO/Chairman of the Board/Director/Founder/President

                  Thomas E. Klema

                  CFO/Chief Accounting Officer/Secretary/Treasurer/Vice President

                  Mr. Kenneth L. Holt

                  Director

                  Patrick J. Bagley

                  Director

                  Ronald D. Boyd

                  Director

                  • Rockwell Medical Inc

                  • 30142 Wixom Road

                  • Wixom, MI 48393

                  • USA.Map

                  • Phone: +1 248 960-9009

                  • Fax: -

                  • rockwellmed.com

                  Incorporated

                  1996

                  Employees

                  286

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: